Profiling the eicosanoid networks that underlie the anti- and pro-thrombotic effects of aspirin.
Animals
Arachidonic Acid
/ administration & dosage
Aspirin
/ pharmacology
Blood Platelets
/ drug effects
Cyclooxygenase 1
/ physiology
Cyclooxygenase Inhibitors
/ pharmacology
Eicosanoids
/ metabolism
Female
Male
Membrane Proteins
/ physiology
Mice
Mice, Inbred C57BL
Mice, Knockout
Thrombosis
/ drug therapy
antithrombotic therapy
aspirin
eicosanoid profiling
endothelium
platelets
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
17
02
2020
revised:
06
05
2020
accepted:
07
05
2020
pubmed:
28
6
2020
medline:
2
3
2021
entrez:
28
6
2020
Statut:
ppublish
Résumé
Aspirin prevents thrombosis by inhibiting platelet cyclooxygenase (COX)-1 activity and the production of thromboxane (Tx)A
Identifiants
pubmed: 32592197
doi: 10.1096/fj.202000312R
pmc: PMC9359103
mid: NIHMS1825952
doi:
Substances chimiques
Cyclooxygenase Inhibitors
0
Eicosanoids
0
Membrane Proteins
0
Arachidonic Acid
27YG812J1I
Cyclooxygenase 1
EC 1.14.99.1
Ptgs1 protein, mouse
EC 1.14.99.1
Aspirin
R16CO5Y76E
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10027-10040Subventions
Organisme : British Heart Foundation
ID : PG/15/79/31777
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/17/40/33028
Pays : United Kingdom
Organisme : Intramural NIH HHS
ID : Z01 ES025034
Pays : United States
Organisme : British Heart Foundation
ID : FS/16/1/31699
Pays : United Kingdom
Organisme : Intramural NIH HHS
ID : Z99 ES999999
Pays : United States
Informations de copyright
© 2020 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.
Références
Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):68-76
pubmed: 17164134
J Clin Invest. 1986 Jan;77(1):202-11
pubmed: 3080473
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17597-602
pubmed: 23045674
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Aug 1;964:26-40
pubmed: 24685839
Cell. 1995 Nov 3;83(3):483-92
pubmed: 8521478
FASEB J. 2016 Dec;30(12):4256-4266
pubmed: 27633788
Blood. 2015 Sep 3;126(10):e11-8
pubmed: 26215112
PLoS One. 2011;6(5):e20062
pubmed: 21629780
J Inflamm (Lond). 2014 Oct 23;11(1):33
pubmed: 25349537
EuroIntervention. 2016 Nov 20;12(10):1239-1245
pubmed: 26606735
N Engl J Med. 2019 Nov 21;381(21):2032-2042
pubmed: 31556978
Am Heart J. 2016 Dec;182:125-134
pubmed: 27914492
Am Heart J. 2007 Jul;154(1):80-6
pubmed: 17584558
Blood. 2018 Aug 2;132(5):e1-e12
pubmed: 29784642
Circulation. 2011 Aug 2;124(5):544-54
pubmed: 21709065
Curr Cardiol Rep. 2016 Aug;18(8):81
pubmed: 27423939
J Thromb Haemost. 2011 Oct;9(10):2050-6
pubmed: 21794076
Circulation. 2015 Feb 17;131(7):633-42
pubmed: 25492024
Br J Pharmacol. 2019 Apr;176(8):988-999
pubmed: 29512148
JAMA Cardiol. 2019 Nov 1;4(11):1092-1101
pubmed: 31557763
Blood. 2018 Aug 2;132(5):465-466
pubmed: 30072414
Nat Med. 2011 Nov 07;17(11):1423-36
pubmed: 22064432
J Pharmacol Exp Ther. 2011 Feb;336(2):391-402
pubmed: 21059804
Acta Cardiol. 2009 Apr;64(2):157-65
pubmed: 19476106
FASEB J. 2013 Oct;27(10):3938-46
pubmed: 23792301
Circ Res. 2019 Oct 11;125(9):847-854
pubmed: 31510878
Nat Med. 2002 Nov;8(11):1227-34
pubmed: 12411949
Platelets. 2012;23(5):344-51
pubmed: 22436052
Heart. 2010 Nov;96(21):1693-4
pubmed: 20956485
Thromb Haemost. 2019 Aug;119(8):1311-1320
pubmed: 31129913
Prostaglandins Leukot Med. 1984 Apr;14(1):41-6
pubmed: 6427791
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Free Radic Res. 2005 Jun;39(6):629-36
pubmed: 16036341
Biochim Biophys Acta. 1982 Jan 12;714(1):122-8
pubmed: 6799004
Biochem Pharmacol. 1988 Apr 1;37(7):1275-80
pubmed: 2965590
Circulation. 2016 Dec 6;134(23):1881-1906
pubmed: 27920074
Br J Pharmacol. 1981 Apr;72(4):697-705
pubmed: 7284687
Br J Pharmacol. 1993 Apr;108(4):901-6
pubmed: 8485629
J Pharm Pharmacol. 1998 Nov;50(11):1275-9
pubmed: 9877314
Blood. 2013 Nov 7;122(19):3349-58
pubmed: 23861251
Cardiovasc Res. 2020 Oct 1;116(12):1972-1980
pubmed: 31688905
Front Pharmacol. 2010 Oct 14;1:116
pubmed: 21607067
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3100-5
pubmed: 9501222
FASEB J. 2015 Nov;29(11):4568-78
pubmed: 26183771
N Engl J Med. 2005 Dec 1;353(22):2373-83
pubmed: 16319386
Biochim Biophys Acta. 1986 Feb 28;875(3):641-53
pubmed: 3081039
Am Heart J. 2016 Nov;181:92-100
pubmed: 27823698
Circ Res. 1992 Dec;71(6):1305-13
pubmed: 1385004
J Clin Invest. 1982 Jun;69(6):1366-72
pubmed: 7045161
Nat New Biol. 1971 Jun 23;231(25):232-5
pubmed: 5284360
Lancet. 2009 May 30;373(9678):1849-60
pubmed: 19482214
Eur Heart J. 1993 Dec;14 Suppl K:88-93
pubmed: 8131796
J Pharmacol Exp Ther. 2019 Sep;370(3):416-426
pubmed: 31248980
J Clin Invest. 2012 Apr;122(4):1459-68
pubmed: 22406532
J Clin Invest. 1983 Mar;71(3):676-88
pubmed: 6338043
J Exp Med. 2007 Feb 19;204(2):311-20
pubmed: 17242161
J Biol Chem. 2018 Mar 2;293(9):3281-3292
pubmed: 29298899
J Lipid Res. 2002 Sep;43(9):1563-78
pubmed: 12235189
Blood. 1992 Dec 1;80(11):2765-73
pubmed: 1333301
J Pharmacol Exp Ther. 1983 Apr;225(1):57-60
pubmed: 6834277